Tudor I. Oprea

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Keith J. Kelleher

> Home > Persons > Tudor I. Oprea

Publications

2023
[j55]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/nar/KelleherSMYMSNJVSHSPBEMO23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nar/KelleherSMYMSNJVSHSPBEMO23
Keith J. Kelleher, Timothy Sheils, Stephen L. Mathias, Jeremy J. Yang, Vincent T. Metzger, Vishal B. Siramshetty, Dac-Trung Nguyen, Lars Juhl Jensen, Dusica Vidovic, Stephan C. Schürer, Jayme Holmes, Karlie R. Sharma, Ajay Pillai, Cristian Bologa, Jeremy S. Edwards, Ewy A Mathé, Tudor I. Oprea:
Pharos 2023: an integrated resource for the understudied human proteome. Nucleic Acids Res. 51(D1): 1405-1416 (2023)
2021
[j48]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/nar/SheilsMKSNBJVKS21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nar/SheilsMKSNBJVKS21
Timothy Sheils, Stephen L. Mathias, Keith J. Kelleher, Vishal B. Siramshetty, Dac-Trung Nguyen, Cristian Bologa, Lars Juhl Jensen, Dusica Vidovic, Amar Koleti, Stephan C. Schürer, Anna Waller, Jeremy J. Yang, Jayme Holmes, Giovanni Bocci, Noel Southall, Poorva Dharkar, Ewy A Mathé, Anton Simeonov, Tudor I. Oprea:
TCRD and Pharos 2021: mining the human proteome for disease biology. Nucleic Acids Res. 49(Database-Issue): D1334-D1346 (2021)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.